Basit öğe kaydını göster

dc.contributor.authorDilber, C
dc.contributor.authorDagdemir, A
dc.contributor.authorAlbayrak, D
dc.contributor.authorAlbayrak, S
dc.contributor.authorKalayci, AG
dc.contributor.authorAliyazicioglu, Y
dc.contributor.authorBasoglu, T
dc.date.accessioned2020-06-21T15:38:46Z
dc.date.available2020-06-21T15:38:46Z
dc.date.issued2004
dc.identifier.issn8756-3282
dc.identifier.issn1873-2763
dc.identifier.urihttps://doi.org/10.1016/j.bone.2004.04.005
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21436
dc.descriptionWOS: 000222494100038en_US
dc.descriptionPubMed: 15207771en_US
dc.description.abstractPurpose: To evaluate whether repeated courses of high-dose methylprednisolone (HDMP) affect the lumbar spine bone mineral density (BMD) in children with chronic idiopathic thrombocytopenic purpura (ITP). Materials and methods: This study included 24 patients with chronic ITP and 149 healthy controls. The patients were allocated into three groups according to the number of HDMP courses (30 mg/kg per day as a single dose for 7 days); group I (10 patients), group 2 (9 patients), and group 3 (5 patients) had received less than 5, 6 - 10, and more than 10 courses, respectively. Lumbar spine BMD and body composition were measured using dual energy X-ray absorptiometry of lumbar spine (L2-L4), and volumetric bone mineral density (vBMD) values were calculated and compared with the controls. The z score of the vBMD was also calculated and compared in the patients of each other groups. Serum markers of the bone turnover were measured to exclude other factors that could effect BMD. Results: The vBMD values of the patients, corrected BMDs for age, were significantly lower than the values of controls (P = 0.018). It was significantly lower in group 3 than groups I and 2 (P = 0.005 and P = 0.006, respectively), but there was no statistically significant difference between groups I and 2 (P = 0.87). The vBMD z scores were significantly lower in group 3 than in groups I and 2 (P = 0.003 and P = 0.004, respectively), and also in group 2 than in group I (P = 0.034). There were a weak negative correlation between the cumulative dose of HDMP and vBMD (r = -0.39, P = 0.054), and strong negative correlation between the cumulative dose of HDMP and vBMD z score (r = -0.63, P = 0.001). Conclusion: Children with chronic ITP are at risk for decreased BMD because of the repeated courses of HDMP; especially more than 2 100 mg of cumulative dose. We therefore recommend that BMD should be monitored in patients with chronic ITP who received repeated courses of HDMP. (C) 2004 Elsevier Inc. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.relation.isversionof10.1016/j.bone.2004.04.005en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectchronic idiopathic thrombocytopenic purpuraen_US
dc.subjectbone mineral densityen_US
dc.subjectcorticosteroiden_US
dc.subjecthigh-dose methylprednisoloneen_US
dc.titleReduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisoloneen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume35en_US
dc.identifier.issue1en_US
dc.identifier.startpage306en_US
dc.identifier.endpage311en_US
dc.relation.journalBoneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster